Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF

Translate this page into:

Letter to the Editor - Case Letter
2015:81:5;527-529
doi: 10.4103/0378-6323.162324
PMID: 26261138

Tuberous sclerosis presenting with late onset seizures and scrotal angiofibromas

Rahul Ray1 , Kirti Jangid1 , Biju Vasudevan1 , Jandhyala Sridhar1 , Aarti Trehan2 , Rohan Kodgule2
1 Department of Dermatology, INHS Asvini, Mumbai, Maharashtra, India
2 Department of Pathology, INHS Asvini, Mumbai, Maharashtra, India

Correspondence Address:
Biju Vasudevan
Department of Dermatology, INHS Asvini, Mumbai - 400 005, Maharashtra
India
How to cite this article:
Ray R, Jangid K, Vasudevan B, Sridhar J, Trehan A, Kodgule R. Tuberous sclerosis presenting with late onset seizures and scrotal angiofibromas. Indian J Dermatol Venereol Leprol 2015;81:527-529
Copyright: (C)2015 Indian Journal of Dermatology, Venereology, and Leprology

Sir,

Tuberous sclerosis, also known as Bourneville′s disease, is an autosomal dominant genetic disorder classically characterized by the triad of mental retardation, seizures and facial angiofibromas. Neurological presentation of tuberous sclerosis occurs typically in children with seizures and intellectual impairment. However, approximately 50% of patients who fulfill the diagnostic criteria have normal intellect and 15% remain free from seizures. Genetic studies have shown that two-thirds of cases do not have affected parents, and in such cases the disease results from a new dominant mutation either in the tuberous sclerosis 1 [TSC1] gene on chromosome 9q34 or the tuberous sclerosis 2 [TSC2] gene on chromosome 16p13.3, with the latter accounting for an estimated 78% of cases. [1]

A 65-year-old man from Maharashtra developed a single episode of generalized tonic-clonic seizure one day prior to presentation. There was no preceding history of fever, cough, diarrhea or fall. He gave no history of seizures in the past. He was referred to the dermatology department for skin lesions on the face, which were present since childhood. There was no history of similar skin findings or associated symptoms in siblings or parents. On examination, he was found to have facial angiofibromas [Figure - 1]a and b, forehead plaques [Figure - 1]c, hypopigmented plaques over lower back and gluteal region suggestive of shagreen patch [Figure - 1]d. He also had coarse pits on the teeth, longitudinal grooves over toe nails of both feet and a few periungual fibromas [Figure - 2]a. He also had an incidental finding of nevus sebaceous [Figure - 2]b on the right side of scalp present since childhood. Genital examination revealed skin colored to erythematous, asymptomatic, sessile and pedunculated lesions over scrotum, which was present since childhood [Figure - 3]. Ophthalmological evaluation was normal. He was admitted and treated with phenytoin orally.

Figure 1: (a) Angiofibromas on the face (b) Close up of angiofibromas (c) Forehead plaque (d) Shagreen patch
Figure 2: (a) Periungual fibromas (b) Nevus sebaceous
Figure 3: Acrochordon like scrotal angiofibromas

Investigations revealed normal hemogram, liver function tests and blood sugar level. However, deranged renal function with a serum creatinine level of 1.8 mg/dl was detected. Computed tomography (CT) scan brain revealed subependymal calcified nodules while that of the abdomen showed bilateral renal cysts. Echocardiography of the heart was essentially within normal limits. Detailed evaluation of other systems revealed no other abnormalities. The serological test for human immunodeficiency virus (HIV) was negative. No evidence for any other cause for epilepsy was detected. Histopathology of the scrotal lesions revealed coarse collagen bundles around proliferating dilated blood vessels, consistent with angiofibroma [Figure - 4].Since creatinine levels were not very high as to require dialysis, only a low protein diet was advised.

Figure 4: Histopathology of scrotal lesions (a) Coarse collagen fibers surrounding proliferating and dilated blood vessels (H and E, ×100) (b) Dilated capillaries (H and E, ×400)

Bourneville′s disease (tuberous sclerosis) is clinically characterized by the triad of refractory epilepsy, mental retardation (sometimes severe) and angiofibromas of the face (typical for 70-90% of the patients), along with other types of cutaneous lesions. In the brain, there are hamartomas and calcified tubers/nodules (cortical brain stones), which cause refractory epilepsy and hydrocephalus. Angiofibromata (formerly misnamed adenoma sebaceum) consist of a proliferation of fibroblasts around blood vessels. Other lesions include angiolieomyomas of the kidneys, liver, testis, adrenal gland, rhabdomyomas of the heart and retinal glial nodules. Subependymal calcified nodules are typical of subependymal hamartomas associated with tuberous sclerosis. They are found mostly along the lateral ventricles. In 10-15% of patients, subependymal nodules can transform into giant cell astrocytomas. They also frequently calcify with increasing age and can cause obstructive hydrocephalus.

Our patient met the modified criteria for the diagnosis of tuberous sclerosis [Table - 1]. The characteristic features of the syndrome are skin lesions, mental retardation and epilepsy, but these show very wide variation in age of onset and severity. Onset before the age of 5 years with cutaneous changes or with epilepsy is usual, although the disease may remain latent until adolescence or adult life. [2],[3] Late onset epilepsy has been described as late as 59 years. [4] However, occurrence of the first episode of seizure at 65 years in our patient is probably one of the latest ages at which it has been described. The seizures are most likely due to the calcified subependymal nodules, probably astrocytomas, The patient is being treated with antiepileptics and is under consideration for surgery/oral rapamycin.

Table 1: Criteria for diagnosis of tuberous sclerosis

Skin lesions are found in 60-70% of cases. Lesions of four types are pathognomonic, angiofibromas, periungual fibromas (Koenen′s tumours), shagreen patch, and white ovoid or ash-leaf-shaped macules. Angiofibromas have been described on face and vulva. However, we were unable to find any previous reports of scrotal angiofibromas. Acrochordon-like angiofibromas on the scrotum appears to be a novel finding.

Rapamycin is an immunosuppressant which forms a inhibitory complex with immunophilin FKBP12, and binds to and inhibits mammalian target of rapamycin (mTOR). It prevents activation of T and B cells by inhibiting their response to interleukin 2. It also has anti-neoplastic effects exerted through the downregulation of angiogenesis and the correction of aberrant growth signals. It has opened up new therapeutic options in tuberous sclerosis and has been found to reduce associated tumors in the brain, skin, and kidneys. [5] It is poorly water soluble, limiting its bioavailability. Rapamycin exhibits linear pharmacokinetics over the dose range of 1-25 mg. Peak plasma levels are generally reached 0.5-2 h after an infusion. A total of 85% of the drug is bound to plasma protein and the half-life is 55 h. Elimination occurs primarily through the feces with only a small portion found in the urine. It is available in the market in two formulations: oral solution (60 mg per 60 ml) and tablets of 1 and 2 mg. Rapamycin for systemic manifestations is usually initiated at 0.2 mg/kg/day (1 mg/day) and titrated with adverse effects to as high as 5 mg/day. Serum levels of 11 and 13 ng/ml are to be maintained during the course. Everolimus, a derivative and prodrug for rapamycin has been Food and Drug Administration (FDA) approved for subependymal giant cell astrocytoma not amenable to surgery. It is also proposed as an antiepileptic medication in cases of epileptogenic cortical dysplasia and has been shown to reduce seizures and cognitive defects. This makes the early diagnosis of tuberous sclerosis even more important in the present day world.

Rapamycin also has a role in reducing skin lesions, especially facial angiofibromas. [6] Inhibition of mTOR pathway by topical rapamycin decreases the output of vascular endothelial growth factor (VEGF) by inhibiting hypoxia-inducible factor (HIF) expression and by directly repressing endothelial cell proliferation. Presently, rapamycin is only available as pharmacy made preparations of 0.1% in white soft paraffin ointment for facial angiofibromas. Rapamycin tablet crushed into 30 ml of 1% ointment or oral solution of rapamycin (1 mg/ml) are the usual methods employed for topical use.

References
1.
Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 2001;68:64-80.
[Google Scholar]
2.
Fryer AE, Osbourne JP. Tuberous sclerosis: A clinical appraisal. Pediatr Rev Commun 1987;1:239-55.
[Google Scholar]
3.
Osborne JP. Diagnosis of tuberous sclerosis. Arch Dis Child 1988;63:1423-5.
[Google Scholar]
4.
Zarei M, Collins VP, Chandran S, Valler D, Higgins JN, Compston DA, et al. Tuberous sclerosis presenting in late adult life. J Neurol Neurosurg Psychiatry 2002;73:436-8.
[Google Scholar]
5.
Wienecke R, Fackler I, Linsenmaier U, Mayer K, Licht T, Kretzler M. Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex. Am J Kidney Dis 2006;48:e27-9.
[Google Scholar]
6.
DeKlotz CM, Ogram AE, Singh S, Dronavalli S, MacGregor JL. Dramatic improvement of facial angiofibromas in tuberous sclerosis with topical rapamycin: Optimizing a treatment protocol. Arch Dermatol 2011;147:1116-7
[Google Scholar]

Fulltext Views
2,519

PDF downloads
683
Show Sections